SPRINGWORKS THERAPEUTICS, INC. Research and Development Expense
SPRINGWORKS THERAPEUTICS, INC. reported Research and Development Expense of $49.59 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-05-09
- SPRINGWORKS THERAPEUTICS, INC. research and development expense for the quarter ending 2025-03-31 was $49.59M, a 7.51% decline year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. research and development expense for the quarter ending 2024-12-31 was $60.24M, a 38.00% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. research and development expense for the quarter ending 2024-09-30 was $42.30M, a 12.93% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. research and development expense for the quarter ending 2024-06-30 was $44.36M, a 23.72% increase year-over-year.
- SPRINGWORKS THERAPEUTICS, INC. research and development expense for fiscal 2024 was $200.52M, a 33.25% increase from fiscal 2023.
- SPRINGWORKS THERAPEUTICS, INC. research and development expense for fiscal 2023 was $150.49M, a 2.99% increase from fiscal 2022.
- SPRINGWORKS THERAPEUTICS, INC. research and development expense for fiscal 2022 was $146.12M, a 43.71% increase from fiscal 2021.
- SPRINGWORKS THERAPEUTICS, INC. research and development expense for fiscal 2021 was $101.68M, a 96.06% increase from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 4 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2025-03-31 | $49.59M 10-Q · filed 2025-05-09 | $109.83M derived: sum of 2 quarters · filed 2025-05-09 | $152.13M derived: sum of 3 quarters · filed 2025-05-09 | $196.49M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2024-12-31 | $60.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $102.53M derived: sum of 2 quarters · filed 2025-02-20 | $146.90M derived: sum of 3 quarters · filed 2025-02-20 | $200.52M 10-K · filed 2025-02-20 | |
| 2024-09-30 | $42.30M 10-Q · filed 2024-11-12 | $86.66M derived: sum of 2 quarters · filed 2024-11-12 | $140.28M 10-Q · filed 2024-11-12 | $183.93M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2024-06-30 | $44.36M 10-Q · filed 2024-08-07 | $97.98M 10-Q · filed 2024-08-07 | $141.64M derived: sum of 3 quarters · filed 2025-05-09 | $179.09M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2024-03-31 | $53.62M 10-Q · filed 2025-05-09 | $97.27M derived: sum of 2 quarters · filed 2025-05-09 | $134.73M derived: sum of 3 quarters · filed 2025-05-09 | $170.59M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $43.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $81.11M derived: sum of 2 quarters · filed 2025-02-20 | $116.96M derived: sum of 3 quarters · filed 2025-02-20 | $150.49M 10-K · filed 2025-02-20 | |
| 2023-09-30 | $37.45M 10-Q · filed 2024-11-12 | $73.31M derived: sum of 2 quarters · filed 2024-11-12 | $106.83M 10-Q · filed 2024-11-12 | $144.76M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-06-30 | $35.86M 10-Q · filed 2024-08-07 | $69.38M 10-Q · filed 2024-08-07 | $107.31M derived: sum of 3 quarters · filed 2025-02-20 | $143.38M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2023-03-31 | $33.52M 10-Q · filed 2024-05-02 | $71.45M derived: sum of 2 quarters · filed 2025-02-20 | $107.52M derived: sum of 3 quarters · filed 2025-02-20 | $145.54M derived: sum of 4 quarters · filed 2025-02-20 | |
| 2022-12-31 | $37.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $74.00M derived: sum of 2 quarters · filed 2025-02-20 | $112.02M derived: sum of 3 quarters · filed 2025-02-20 | $146.12M 10-K · filed 2025-02-20 | |
| 2022-09-30 | $36.07M 10-Q · filed 2023-11-02 | $74.09M derived: sum of 2 quarters · filed 2023-11-02 | $108.19M 10-Q · filed 2023-11-02 | $137.54M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $38.02M 10-Q · filed 2023-08-02 | $72.13M 10-Q · filed 2023-08-02 | $101.47M derived: sum of 3 quarters · filed 2024-02-27 | $124.34M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $34.10M 10-Q · filed 2023-05-03 | $63.45M derived: sum of 2 quarters · filed 2024-02-27 | $86.31M derived: sum of 3 quarters · filed 2024-02-27 | $118.40M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $29.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $52.21M derived: sum of 2 quarters · filed 2024-02-27 | $84.30M derived: sum of 3 quarters · filed 2024-02-27 | $101.68M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $22.87M 10-Q · filed 2022-11-03 | $54.96M derived: sum of 2 quarters · filed 2022-11-03 | $72.33M 10-Q · filed 2022-11-03 | $87.59M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $32.09M 10-Q · filed 2022-08-04 | $49.47M 10-Q · filed 2022-08-04 | $64.73M derived: sum of 3 quarters · filed 2023-02-28 | $78.65M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $17.38M 10-Q · filed 2022-05-05 | $32.64M derived: sum of 2 quarters · filed 2023-02-28 | $46.56M derived: sum of 3 quarters · filed 2023-02-28 | $59.51M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $15.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $29.18M derived: sum of 2 quarters · filed 2023-02-28 | $42.13M derived: sum of 3 quarters · filed 2023-02-28 | $51.86M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $13.92M 10-Q · filed 2021-11-04 | $26.87M derived: sum of 2 quarters · filed 2021-11-04 | $36.60M 10-Q · filed 2021-11-04 | $48.77M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $12.95M 10-Q · filed 2021-08-04 | $22.67M 10-Q · filed 2021-08-04 | $34.85M derived: sum of 3 quarters · filed 2022-02-24 | $45.59M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $9.73M 10-Q · filed 2021-05-05 | $21.90M derived: sum of 2 quarters · filed 2022-02-24 | $32.64M derived: sum of 3 quarters · filed 2022-02-24 | $43.85M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $12.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $22.92M derived: sum of 2 quarters · filed 2022-02-24 | $34.12M derived: sum of 3 quarters · filed 2022-02-24 | $42.55M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $10.74M 10-Q · filed 2020-11-12 | $21.95M derived: sum of 2 quarters · filed 2020-11-12 | $30.37M 10-Q · filed 2020-11-12 | $34.08M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $11.21M 10-Q · filed 2020-08-12 | $19.63M 10-Q · filed 2020-08-12 | $23.33M derived: sum of 3 quarters · filed 2021-02-25 | $26.74M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $8.42M 10-Q · filed 2020-05-12 | $12.13M derived: sum of 2 quarters · filed 2021-02-25 | $15.54M derived: sum of 3 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $7.11M derived: sum of 2 quarters · filed 2021-02-25 | $9.90M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $3.41M 10-Q · filed 2019-11-12 | $6.19M 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $2.80M 10-K · filed 2020-03-12 |